Companies / Sierra Oncology, Inc.
Sierra Oncology, Inc.
SRRACIK 1290149
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | Vivo Opportunity, LLC Director | Other Sold to issuer | Common Stock | $150.47M | -2.7M -100.00% | 0 | low |
| Jul 1, 2022 | Aggarwal Gaurav Director | Other Sold to issuer | Common Stock | $150.47M | -2.7M -100.00% | 0 | low |
| Jul 1, 2022 | Orbimed Advisors LLC Director | Other Sold to issuer | Common Stock | $83.12M | -1.5M -100.00% | 0 | low |
| Jul 1, 2022 | Ashiya Mona Director | Other Sold to issuer | Common Stock | $83.12M | -1.5M -100.00% | 0 | low |
| Jul 1, 2022 | Sinclair Andrew Director | Other Sold to issuer | Common Stock, $0.001 par value | $72.28M | -1.3M -100.00% | 0 | low |
| Jul 1, 2022 | Vivo Opportunity, LLC Director | Other Sold to issuer | Common Stock | $23.76M | -432K -100.00% | 0 | low |
| Jan 31, 2022 | Vivo Opportunity, LLC Director | Buy Open-market buy | Common Stock | $21.60M | +800K +41.33% | 2,735,853 | high |
| Jan 31, 2022 | Aggarwal Gaurav Director | Buy Open-market buy | Common Stock | $21.60M | +800K +41.33% | 2,735,853 | high |